Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
C409065-1ml
|
1ml |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$222.90
|
|
| Synonyms | MK-401 | 4-amino-6-(1,2,2-trichloroethenyl)-1,3-benzenedisulfonamide |
|---|---|
| Specifications & Purity | 10mM in DMSO |
| Biochemical and Physiological Mechanisms | Clorsulon (MK-401) is used in the treatment of Fasciola hepatica infections in calves and sheep. |
| Storage Temp | Store at -80°C |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Product Description |
Information Clorsulon (MK-401) is used in the treatment of Fasciola hepatica infections in calves and sheep. Clorsulon is a competitive inhibitor of both 3-phosphoglycorate and ATP and had a Ki of 0.29 mM, inhibits glucose utilization and acetate and propionate formation by mature Fasciola hepatica in vitro. In vivo Clorsulon (a single dose of 15 mg/kg) is effective in removing over 90% of immature Fasciola hepatica from sheep (6 weeks after infection) and calves (8 weeks after infection). A 2.5 mg/kg dose removed over 90% of mature (16 weeks old) liver fluke from sheep. Clorsulon causes severe disruption to the tegument and gut of Fasciola hepatica after in vivo incubation. cell lines:NHEK, A431, MCF-7, and MDA-468 Concentrations: Incubation Time: Powder Purity:≥99% |
| ALogP | 0.155 |
|---|---|
| hba_count | 4 |
| HBD Count | 3 |
| Rotatable Bond | 3 |
| Smiles | NC1=CC(=C(C=C1[S](N)(=O)=O)[S](N)(=O)=O)C(Cl)=C(Cl)Cl |
|---|---|
| Molecular Weight | 380.66 |
| Reaxy-Rn | 2821757 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=2821757&ln= |
| DMSO(mg / mL) Max Solubility | 76 |
|---|---|
| DMSO(mM) Max Solubility | 199.65 |
| Water(mg / mL) Max Solubility | <1 |